Compare

Veeva Systems/$VEEV

1D1W1M3M6MYTD1Y5YMAX

About Veeva Systems

Veeva is the global leading supplier of cloud-based software solutions for the life sciences industry. The company's best-of-breed offerings address operating and regulatory requirements for customers ranging from small, emerging biotechnology companies to departments of global pharmaceutical manufacturers. The company leverages its domain expertise to improve the efficiency and compliance of the underserved life sciences industry, displacing large, highly customized and dated enterprise resource planning systems that have limited flexibility. Its two main products are Veeva CRM, a customer relationship management platform for companies with a salesforce, and Veeva Vault, a content management platform that tackles various functions within any life sciences company.
Ticker
$VEEV
Sector
Health
Primary listing
NYSE
Employees
7,928

Veeva Systems Metrics

BasicAdvanced
$43B
43.10
$6.10
0.97
-

What the Analysts think about Veeva Systems

Analyst ratings (Buy, Hold, Sell) for Veeva Systems stock.
Analyst projections of the future price of Veeva Systems stock.

Bulls say / Bears say

Second-quarter revenue rose 18% year on year and subscription revenue grew 16%; operating income rose 40%, and management raised its full-year outlook. That gives Veeva a strong base of recurring growth and profitability. (Veeva Systems)
Vault CRM adoption is building among major customers: by November, more than 200 customers were live and 14 of the top 20 biopharmas had committed. UCB’s November selection adds another large customer to the migration pipeline. (CMC Markets, Veeva Systems)
Veeva has room to sell more software and AI tools into a specialised market: management estimates a $30 billion life-sciences opportunity, with only 12% penetrated, and says Vault AI is priced as an add-on to existing Vault subscriptions. Falcon could provide another growth avenue as it moves towards initial customer launches. (Stock Analysis, Veeva Systems)
The CRM transition exposes Veeva to direct competition at a key point in its customer relationships. Management said some large customers chose Salesforce, and acknowledged that winning them back may be only partial or may not happen; migrations are expected to continue through 2029. (EarningsCalls.dev, CMC Markets)
The shares carry high expectations: a November analyst report put Veeva at about 49 times earnings and roughly 23 times forward EBITDA. That premium could leave the share price vulnerable if growth or the CRM migration falls short. (Investing.com)
AI may take time to become a meaningful revenue driver. At Investor Day, management described Falcon as being in early adoption, said its sales pipeline was still just a pipeline and declined to quantify the expected contribution for the coming year. (Stock Analysis)
Data summarised monthly by Lightyear AI. Last updated on 19 Nov 2026.

Veeva Systems Financial Performance

Revenues and expenses
Income statement
AnnuallyQuarterly
2023
YoY growth
Revenue
Net income
Profit margin

Veeva Systems Earnings Performance

Company profitability
Earnings per share
AnnuallyQuarterly
2020
2021
2022
2023
2024
Actual
Expected
Surprise
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.